<DOC>
	<DOCNO>NCT00001520</DOCNO>
	<brief_summary>Neuromuscular block agent commonly use facilitate endotracheal intubation . Succinylcholine , ultra short-acting , depolarize neuromuscular blocking agent , commonly use agent paralysis set rapid onset short duration paralysis . In patient contraindication succinylcholine difficult airway anticipate , neuromuscular block agent pharmacodynamic profile similar succinylcholine would attractive alternative . Rocuronium , new intermediate-acting nondepolarizing neuromuscular block agent produce paralysis within 60 second , similar succinylcholine , duration paralysis approximately 20 30 minute . If rocuronium-induced paralysis could chemically reverse within 10 15 minute administration intubate dose , may appropriate alternative patient contraindication succinylcholine patient difficult airway anticipate . Neostigmine anticholinesterase agent inhibits hydrolysis acetylcholine compete acetylcholine attachment acetylcholinesterase . Inhibition breakdown acetylcholine allows neurotransmitter present neuromuscular junction longer period time , molecule bind repeatedly acetylcholine receptor . The purpose study determine dose neostigmine necessary early reversal rocuronium-induced paralysis .</brief_summary>
	<brief_title>The Early Reversibility Rocuronium After Different Doses Neostigmine</brief_title>
	<detailed_description>Neuromuscular block agent commonly use facilitate endotracheal intubation . Succinylcholine , ultra short-acting , depolarize neuromuscular blocking agent , commonly use agent paralysis set rapid onset short duration paralysis . In patient contraindication succinylcholine difficult airway anticipate , neuromuscular block agent pharmacodynamic profile similar succinylcholine would attractive alternative . Rocuronium , new intermediate-acting nondepolarizing neuromuscular block agent produce paralysis within 60 second , similar succinylcholine , duration paralysis approximately 20 30 minute . If rocuronium-induced paralysis could chemically reverse within 10 15 minute administration intubate dose , may appropriate alternative patient contraindication succinylcholine patient difficult airway anticipate . Neostigmine anticholinesterase agent inhibits hydrolysis acetylcholine compete acetylcholine attachment acetylcholinesterase . Inhibition breakdown acetylcholine allows neurotransmitter present neuromuscular junction longer period time , molecule bind repeatedly acetylcholine receptor . The purpose study determine dose neostigmine necessary early reversal rocuronium-induced paralysis .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>American Society Anethesiology Class IIII adult patient undergo elective surgery require neuromuscular blockage endotracheal intubation . No preexist renal hepatic disease , MyastheniaGravis , EatonLambert Disease , pregnancy , concurrent anticonvulsant therapy , history hypersensitivity rocuronium , neostigmine , glycopyrrolate .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1999</verification_date>
	<keyword>Endotracheal Intubation</keyword>
	<keyword>Neuromuscular Blockade</keyword>
	<keyword>Neuromuscular Blocking Agents</keyword>
	<keyword>Paralysis</keyword>
	<keyword>Reversal Agents</keyword>
</DOC>